Ramdevbaba Solvent Limited (NSE SME:RBS) rose 19.93% to INR 73.70, and this move looks more financial than speculative once you unpack the company’s filings. The company’s prospectus and annual report show that it is engaged in the extraction and refining of rice bran oil, and its FY2025 annual report records total revenue from operations of INR 93,559.24 lakh, up from INR 69,298.79 lakh in FY2024. Net profit rose to around INR 1,503.14 lakh from INR 1,303.28 lakh, while EBITDA was cited around INR 3,298.79 lakh in the annual-report commentary. Those are meaningful improvements, and they help explain why a relatively underfollowed process-industry stock would suddenly attract aggressive interest.

The company’s background also matters. Ramdevbaba Solvent converted from private to public in late 2023 and came to market through the SME route, so the market is still in the early stages of figuring out what multiple to assign. That creates fertile ground for sharp price moves whenever the financials show momentum. In businesses tied to edible oils and agro-processing, scale matters, but so do margins, working capital, and the ability to grow without blowing up the balance sheet. Ramdevbaba’s filings show a business that is growing revenue and profit while navigating that scaling phase.

The ratio disclosures are particularly revealing. The annual report shows a net profit ratio around 2%, which is thin but stable for the sector, while certain turnover and capital ratios changed materially due to working-capital and share-capital changes after listing. The company itself attributes some ratio changes to changes in share capital and net working capital. That is a reminder that this is not a high-margin consumer franchise; it is a processing business where execution and efficiency matter more than headline narrative.

So why did the stock jump nearly 20%? Because the market likely sees a classic SME rerating formula: newly public company, visible top-line growth, improving net profit, and exposure to a large domestic edible-oil opportunity. The annual report explicitly notes that domestic demand for edible oils has been increasing faster than domestic production, which supports a medium-term growth narrative. When a company with that backdrop still trades at a trailing P/E of 12.14 and EPS of INR 6.07 from your table, momentum investors naturally begin to ask whether the stock has been undervalued relative to growth.

But there are clear risks. Edible-oil and solvent-extraction businesses are highly exposed to input-cost volatility, margin compression, and commodity-linked swings. A business can grow revenue sharply yet struggle to expand margins if raw-material or realizations turn adverse. The company’s margin profile also means that even modest pricing pressure can hit earnings materially. For that reason, Ramdevbaba may look statistically cheap, but it is not a low-risk compounder.

On valuation, this is perhaps the most interesting stock in the batch because it combines revenue growth, profit growth, and a relatively moderate screen multiple. If investors decide the company deserves a higher SME-growth multiple, the rerating may continue. If not, the stock may settle back into a more commodity-processing-style valuation band.

FAQ
What does Ramdevbaba Solvent do?

It is engaged in extraction and refining of rice bran oil.
Did FY2025 improve financially?

Yes. Revenue and net profit both increased meaningfully year over year.
What is the key risk?

Thin margins and commodity-linked volatility remain the biggest risks.

Conclusion
Ramdevbaba Solvent’s rally looks like a financially supported SME rerating, not just a momentum burst. Revenue growth, profit growth, and a still-reasonable trailing multiple together make it understandable why the market has become suddenly curious.